GTF2I and type 2 diabetes mellitus: this study identified clinically relevant non-coding RNA–based angiogenesis panel (FZD5, GTF2I mRNAs, hsa-miR-1976 and LINC02210 lncRNA) as a biomarker signature associated with type 2 diabetes mellitus complicated by ischemic heart disease.